Adaptive Biotechnologies Corporation - notizie pubblicate 188 - letture 6.189
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q4 2023 Earnings Presentation
Fourth quarter and fy 2023 earnings conference call safe harbor this presentation has been prepared by adaptive biotechnologies corporation ("we," "us," "o ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results - Form 8-K
Adaptive biotechnologies reports fourth quarter and full year 2023 financial results seattle, feb. 14, 2024 (globe newswire) - adaptive biotechnologies corporation ("adaptive ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
Pdf version seattle, feb. 14, 2024 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
Pdf version seattle, jan. 29, 2024 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the gene ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Pdf version seattle, dec. 27, 2023 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the gene ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
Pdf version treatment adapted studies show the potential for mrd assessment to guide the personalization of blood cancer care new data demonstrates mrd assessed from blood in multi ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
Pdf version seattle, dec. 05, 2023 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the gene ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Quarterly Report for Quarter Ending September 30, 2023 (Form 10-Q)
10-q united states securities and exchange commission washington, dc 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update - Form 8-K
Adaptive biotechnologies reports third quarter 2023 financial results and provides business update seattle, nov. 09, 2023 (globe newswire) - adaptive biotechnologies corporation (& ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023
Pdf version seattle, nov. 02, 2023 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the gene ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Announces Launch of Epic Integration for clonoSEQ®
Pdf version the adaptive-epic integration will provide clinicians and patients with easier access to minimal residual disease (mrd) monitoring in blood cancers seattle, sept. 13, 2 ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Management Change - Form 8-K
8-k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of r ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Pdf version seattle, aug. 30, 2023 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti